DNMT3A and Tatton-Brown-Rahman overgrowth syndrome: Given that haploinsufficiency of DNMT3A has been ruled in as a mutational mechanism for Tatton-Brown–Rahman syndrome, it seems likely that all pathogenic variants will prove to be loss of function (Okamoto et al., 2016).